GSK3B and Merkel cell skin cancer: Pyrvinium effectively inhibited the growth of MCC cell lines (Figure 4C), even outperforming the previously reported effective drug CHIR99021, a GSK3β inhibitor sharing the same MOA as indirubin in the L1000 dataset (Figure 4D).